California (Virtual). February 2022.
Topic: Active Surveillance for Patients with Intermediate-Risk Disease: Risk Versus Benefit
Category: Active Surveillance, Prostate Cancer
California (Virtual). February 2022.
Topic: Active Surveillance for Patients with Intermediate-Risk Disease: Risk Versus Benefit
Category: Active Surveillance, Prostate Cancer